Dexcom Inc
F:DC4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dexcom Inc
F:DC4
|
US |
|
S
|
Simon Property Group Inc
F:SQI
|
US |
|
Mitsui Chemicals Inc
OTC:MITUF
|
JP |
|
Proeduca Altus SA
MAD:PRO
|
ES |
|
D
|
DocuSign Inc
F:DS3
|
US |
|
H
|
HeidelbergCement AG
F:HEI
|
DE |
|
C
|
Christian Dior SE
F:DIO
|
FR |
|
B
|
Bengal Energy Ltd
F:8BE
|
CA |
|
Magellan Aerospace Corp
TSX:MAL
|
CA |
|
Carrefour SA
PAR:CA
|
FR |
|
M
|
Magellan Aerospace Corp
OTC:MALJF
|
CA |
|
Addus Homecare Corp
NASDAQ:ADUS
|
US |
|
C
|
Cidara Therapeutics Inc
F:20D
|
US |
Wall St Price Targets
DC4 Price Targets Summary
Dexcom Inc
According to Wall Street analysts, the average 1-year price target for DC4 is 74.54 EUR with a low forecast of 65.71 EUR and a high forecast of 102.01 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DC4's stock price target?
Price Target
74.54
EUR
According to Wall Street analysts, the average 1-year price target for DC4 is 74.54 EUR with a low forecast of 65.71 EUR and a high forecast of 102.01 EUR.
What is the Revenue forecast for Dexcom Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 3 years is 13%.
What is the Gross Profit forecast for Dexcom Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 37%. The projected CAGR for the next 3 years is 15%.
What is the Operating Income forecast for Dexcom Inc?
Projected CAGR
20%
The compound annual growth rate for Operating Income over the next 3 years is 20%.
What is the Pre-Tax Income forecast for Dexcom Inc?
Projected CAGR
19%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.
What is the Net Income forecast for Dexcom Inc?
Projected CAGR
19%
The compound annual growth rate for Net Income over the next 3 years is 19%.
